Insulet Corp
Veridion Score
Composite trend over time
Why is PODD moving today?
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, more than 600,000 insulin-dependent diabetic patients are using it worldwide.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for PODD.
PODD insider activity
Insulet Corp
3 insiders bought in the last 90 days
Net selling: -$1.8M across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
| Filing date | Trade date | Insider | Title | Type | Price | Qty | Owned | Value | Receipt |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-04 | 2026-06-03 | STONESIFER TIMOTHY C. | Insider | buy | $143.51 | 2,790 | 9,041 | $400K | SEC Form 4 |
| 2026-06-04 | 2026-06-03 | BORIO LUCIANA | Insider | sell | $143.27 | 418 | 4,329 | $60K | SEC Form 4 |
| 2026-06-03 | 2026-06-03 | WEATHERMAN ELIZABETH H | Insider | buy | $144.20 | 3,450 | 10,352 | $497K | SEC Form 4 |
| 2026-05-15 | 2026-05-13 | McEvoy Ashley | Insider | sell | $148.84 | 1,411 | 22,551 | $210K | SEC Form 4 |
| 2026-04-02 | 2026-03-31 | Huffines Robert Luther | Insider | buy | $209.84 | 111 | 638 | $23K | SEC Form 4 |
Showing 5 recent rows. Sovereign unlocks 35 additional rows, full sorting, and the named-filer history.
Upgrade to Sovereign · $25/moPODD contract awards, year to date.
Public federal awards linked to this ticker.
PODD lobbying filings, year to date.
Registered lobbying filings matched to Insulet Corp.
INSULET CORPORATION
INSULET CORPORATION
TODD STRATEGY GROUP